Clerio Vision, Inc.

Clerio Vision, Inc. is an ophthalmic technology company that develops advanced vision correction solutions using its proprietary Laser Induced Refractive Index Change (LIRIC) technology. Founded on research from the University of Rochester, the company utilizes femtosecond laser technology to create lens patterns that correct various vision impairments, including presbyopia, myopia, hyperopia, astigmatism, and higher order aberrations. Clerio Vision focuses on non-invasive refractive surgery options and next-generation contact and intraocular lenses. The company’s product platform targets the global ophthalmic market and includes a range of products currently in clinical development. Clerio Vision also addresses the issue of myopia progression in children, aiming to provide effective solutions. With significant funding raised from various investors, including venture capital and angel investors, Clerio Vision is led by a team of experienced entrepreneurs and industry veterans who have a strong background in laser vision correction technologies. In 2019, the company enhanced its capabilities by acquiring Hydrogel Vision Corporation, a manufacturer of Extreme H2O contact lenses.

• Employees 39
• Founded 2014
• Total Funding $40151384